The Patient Signal

In this episode, we explore key developments from the JPMorgan Healthcare Conference, where biotech companies made waves despite the lack of major announcements, highlighting the sector's ongoing growth potential. Chai Discovery's collaboration with Eli Lilly aims to enhance biologics discovery using AI, following a successful Series B funding round. VieCure secured $43 million to expand its AI-powered Halo Intelligence platform, emphasizing democratizing precision medicine. Applied Clinical Trials Online discusses the role of digital technologies in clinical trials, while NVIDIA's partnerships with Eli Lilly and Thermo Fisher aim to integrate AI into drug discovery and laboratory operations. NEJM AI examines cognitive biases in AI systems, stressing the need for fair and accurate applications. The New England Journal of Medicine highlights ethical considerations in medical AI, and JAMA Network Open evaluates AI's reliability in providing nutritional information. Finally, NVIDIA and Eli Lilly's $1 billion investment in an AI co-innovation lab promises to revolutionize drug discovery and manufacturing processes.

Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture.

As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics.

Start your VoiceStream free trial today!